Suzanne de Waha, MD (@suzanne_de_waha) 's Twitter Profile
Suzanne de Waha, MD

@suzanne_de_waha

Cardiologist ❤️

ID: 1604889205896843273

calendar_today19-12-2022 17:19:51

754 Tweet

271 Followers

411 Following

Dr. Jen Wolkin | ADHD + Trauma Therapist (@drjenwolkin) 's Twitter Profile Photo

Trauma did NOT make you stronger. It traumatized you, broke your heart, dysregulated your nervous system, gave you PTSD, sleepless nights, trust issues, connection difficulty, almost killed you, and stole your will to live. YOU make yourself stronger by stepping up to heal.

Roland Tilz (@rolandtilz) 's Twitter Profile Photo

‼️ Breaking news REVIVED-BCIS2 study published! 👉pts. with LVEF <35%, viable myocardium amenable to PCI 👉randomized to PCI plus OMT or OMT ‼️PCI did not ⬇️ all-cause mortality or aborted SCD ‼️no evidence to support delaying ICD implantation 👉"you can not stent VT"

Michel Pompeu Sá (@m_pompeu_sa_md) 's Twitter Profile Photo

🔥Hot off the press🔥 Read our paper in American Journal of Cardiology: sciencedirect.com/science/articl… 💥SAPIEN vs EVOLUT vs PORTICO 💥 #TAVR SEV: better transvalvular hemodynamics across all annular diameters #Brown Sarah Yousef Amber Makani @dkliner412 Catalin Toma, MD #SernaGallegos Ibrahim Sultan

🔥Hot off the press🔥 Read our paper in <a href="/AmJCardio/">American Journal of Cardiology</a>: sciencedirect.com/science/articl…

💥SAPIEN vs EVOLUT vs PORTICO
💥 #TAVR SEV: better transvalvular hemodynamics across all annular diameters

#Brown <a href="/sarahyousefmd/">Sarah Yousef</a> <a href="/Amber_MakaniMD/">Amber Makani</a> @dkliner412 <a href="/CatalinPToma/">Catalin Toma, MD</a> #SernaGallegos <a href="/IbrahimSultanMD/">Ibrahim Sultan</a>
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Breaking news! The AZALEA-TIMI 71 trial of the factor XI/XIa inhibitor abelacimab has been stopped for efficacy. Abelacimab lowered the bleeding endpoint compared with rivaroxaban in patients with atrial fibrillation. If similarly on stroke, this is potentially groundbreaking.

Breaking news! The AZALEA-TIMI 71 trial of the factor XI/XIa inhibitor abelacimab has been stopped for efficacy. Abelacimab lowered the bleeding endpoint compared with rivaroxaban in patients with atrial fibrillation. If similarly on stroke, this is potentially groundbreaking.
Simon Lord 🇺🇦 (@simonmdlord) 's Twitter Profile Photo

79 years ago 31 soldiers of the SAS Regiment were murdered on Hitler's orders and are buried at Moussey in NE France. Someone has anonymously placed a hand-made poppy on each grave.

79 years ago 31 soldiers of the SAS Regiment were murdered on Hitler's orders and are buried at Moussey in NE France.
Someone has anonymously placed a hand-made poppy on each grave.
Mathias Orban (@maorban) 's Twitter Profile Photo

Every question answered for transcatheter mitral repair with COAPT Post Approval Study by Kashish Goel JACC Journals? Check out the Editorial from @Cardio_LMU @LMU_Uniklinikum jörg hausleiter where we outline future directions for valvular #heartfailure authors.elsevier.com/a/1hnDt2d9GHwW…

Suzanne de Waha, MD (@suzanne_de_waha) 's Twitter Profile Photo

STEP-HFpEF: A landmark trial in HFpEF. Studies adequately powered for clinical endpoints will follow. NB: SAE more frequent in placebo arm.

Michelle Kittleson MD PhD (@mkittlesonmd) 's Twitter Profile Photo

This poll sparked a lot of great discussion. . .so what did I decide? Find out here 👇 tctmd.com/news/parenthoo… (And much thanks to Shelley Wood (she/her) for the opportunity to write this.)

Dr Liz O'Riordan (@liz_oriordan) 's Twitter Profile Photo

I love you all - but you’re WRONG! 😜 You should have been telling me to exercise when I said was exhausted from my cancer treatment 👉So much evidence to prove it makes you feel less tired. 🏃‍♀️so I’ve just been for a jog ❓what have you done today?